Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients

Background: High mobility group box 1 protein (HMGB1) is known for its significant elevation in a multitude of tumors and benign diseases. In this study, we investigated the relevance of soluble HMGB1 for the prediction and monitoring of therapy response as well as the estimation of prognosis in adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Handke, Nikolaus A., Rupp, Alexander B. A., Trimpop, Nicolai, von Pawel, Joachim, Holdenrieder, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924191/
https://www.ncbi.nlm.nih.gov/pubmed/33672622
http://dx.doi.org/10.3390/diagnostics11020356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924191/
https://www.ncbi.nlm.nih.gov/pubmed/33672622
http://dx.doi.org/10.3390/diagnostics11020356

Ejemplares similares